Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason Waithman

Showing results (31-40 of 54) with videos related to

Pageof 6
Sort By:
Burns & Trauma|May 4, 2022
Non-severe burn injury increases cancer incidence in mice and has long-term impacts on the activation and function of T cellsLucy W Barrett, Vanessa S Fear, Bree Foley, et al.
Frontiers in Immunology|February 1, 2019
CD8<sup>+</sup>XCR1<sup>neg</sup> Dendritic Cells Express High Levels of Toll-Like Receptor 5 and a Unique Complement of Endocytic ReceptorsBen Wylie, James Read, Anthony C Buzzai, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 24, 2009
Tissue destruction caused by cytotoxic T lymphocytes induces deletional toleranceIan A Parish, Jason Waithman, Gayle M Davey, et al.
Immunity|July 25, 2006
Migratory dendritic cells transfer antigen to a lymph node-resident dendritic cell population for efficient CTL primingRhys S Allan, Jason Waithman, Sammy Bedoui, et al.
Frontiers in Immunology|November 3, 2023
Single cell transcriptomics reveals cell type specific features of developmentally regulated responses to lipopolysaccharide between birth and 5 yearsJames F Read, Michael Serralha, Jesse D Armitage, et al.
Nature Immunology|April 8, 2009
Cross-presentation of viral and self antigens by skin-derived CD103+ dendritic cellsSammy Bedoui, Paul G Whitney, Jason Waithman, et al.
Clinical & Translational Immunology|July 23, 2020
Identifying the optimal donor for natural killer cell adoptive therapy to treat paediatric B- and T-cell acute lymphoblastic leukaemiaBree Foley, Clara Ta, Samantha Barnes, et al.
Frontiers in Immunology|April 21, 2020
Diverse Anti-Tumor Immune Potential Driven by Individual IFNα SubtypesAnthony C Buzzai, Teagan Wagner, Katherine M Audsley, et al.
Cancer Immunology, Immunotherapy : CII|April 9, 2021
Tumour draining lymph node-generated CD8 T cells play a role in controlling lung metastases after a primary tumour is removed but not when adjuvant immunotherapy is usedVanessa S Fear, Catherine A Forbes, Samuel A Neeve, et al.
Frontiers in Immunology|September 23, 2021
IFNβ Is a Potent Adjuvant for Cancer Vaccination StrategiesKatherine M Audsley, Teagan Wagner, Clara Ta, et al.
Pageof 6

Showing results (31-40 of 54) with videos related to

Sort By:
Pageof 6
Burns & Trauma|May 4, 2022
Non-severe burn injury increases cancer incidence in mice and has long-term impacts on the activation and function of T cellsLucy W Barrett, Vanessa S Fear, Bree Foley, et al.
Frontiers in Immunology|February 1, 2019
CD8<sup>+</sup>XCR1<sup>neg</sup> Dendritic Cells Express High Levels of Toll-Like Receptor 5 and a Unique Complement of Endocytic ReceptorsBen Wylie, James Read, Anthony C Buzzai, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 24, 2009
Tissue destruction caused by cytotoxic T lymphocytes induces deletional toleranceIan A Parish, Jason Waithman, Gayle M Davey, et al.
Immunity|July 25, 2006
Migratory dendritic cells transfer antigen to a lymph node-resident dendritic cell population for efficient CTL primingRhys S Allan, Jason Waithman, Sammy Bedoui, et al.
Frontiers in Immunology|November 3, 2023
Single cell transcriptomics reveals cell type specific features of developmentally regulated responses to lipopolysaccharide between birth and 5 yearsJames F Read, Michael Serralha, Jesse D Armitage, et al.
Nature Immunology|April 8, 2009
Cross-presentation of viral and self antigens by skin-derived CD103+ dendritic cellsSammy Bedoui, Paul G Whitney, Jason Waithman, et al.
Clinical & Translational Immunology|July 23, 2020
Identifying the optimal donor for natural killer cell adoptive therapy to treat paediatric B- and T-cell acute lymphoblastic leukaemiaBree Foley, Clara Ta, Samantha Barnes, et al.
Frontiers in Immunology|April 21, 2020
Diverse Anti-Tumor Immune Potential Driven by Individual IFNα SubtypesAnthony C Buzzai, Teagan Wagner, Katherine M Audsley, et al.
Cancer Immunology, Immunotherapy : CII|April 9, 2021
Tumour draining lymph node-generated CD8 T cells play a role in controlling lung metastases after a primary tumour is removed but not when adjuvant immunotherapy is usedVanessa S Fear, Catherine A Forbes, Samuel A Neeve, et al.
Frontiers in Immunology|September 23, 2021
IFNβ Is a Potent Adjuvant for Cancer Vaccination StrategiesKatherine M Audsley, Teagan Wagner, Clara Ta, et al.
Pageof 6